MEMORANDUM OF UNDERSTANDING KANGER INTERNATIONAL BERHAD ("KANGER" OR "THE GROUP") UPDATE ON MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN KANGER AND ZUELLIG PHARMA SDN. BHD. ("ZP")
| KANGER INTERNATIONAL BERHAD |
| Type | Announcement |
| Subject | MEMORANDUM OF UNDERSTANDING |
| Description | KANGER INTERNATIONAL BERHAD ("KANGER" OR "THE GROUP")
UPDATE ON MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN KANGER AND ZUELLIG PHARMA SDN. BHD. ("ZP") |
|
Reference is made to the announcements dated 26 October 2020, 9 March 2021, 3 May 2021, 4 August 2021, 29 November 2021 and 10 March 2022 pertaining to the MOU made between Kanger and ZP for the purpose of collaboration on the distribution of COVID-19 vaccines in Malaysia. The Board of Directors of Kanger wishes to announce that following the approval of Ministry of Health’s Drug Control Authority Malaysia of another company as the registered holder for Sinopharm COVID-19 vaccine in Malaysia, Kanger and ZP has on 18 May 2022 terminated the MOU. This announcement is dated 18 May 2022. |
|
Announcement Info
| Company Name | KANGER INTERNATIONAL BERHAD |
| Stock Name | KANGER |
| Date Announced | 18 May 2022 |
| Category | General Announcement for PLC |
| Reference Number | GA1-18052022-00033 |